Self-Defeating Codes of Medical Ethics and How to Fix Them: Failures in COVID-19 Response and Beyond

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

(2020) Alfred H.J. Kim et al.   ANNALS OF INTERNAL MEDICINE

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

(2020) Philippe Gautret et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Against pandemic research exceptionalism

(2020) Alex John London et al.   SCIENCE

Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?

(2020) Julian D Machiels et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments

(2020) Robert M. Califf et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov

(2020) Krishna Pundi et al.   JAMA Internal Medicine

Estimation of clinical trial success rates and related parameters

(2018) Chi Heem Wong et al.   BIOSTATISTICS

Clinical Trials in Medical Center Advertising

(2018) Alex John London et al.   JAMA Oncology

Social value, clinical equipoise, and research in a public health emergency

(2018) Alex John London   BIOETHICS

Learning health systems, clinical equipoise and the ethics of response adaptive randomisation

(2017) Alex John London   JOURNAL OF MEDICAL ETHICS

The Structure of Clinical Translation:Efficiency, Information, and Ethics

(2015) Jonathan Kimmelman et al.   HASTINGS CENTER REPORT

The Ethics of Advertising for Health Care Services

(2014) Yael Schenker et al.   AMERICAN JOURNAL OF BIOETHICS

Clinical development success rates for investigational drugs

(2014) Michael Hay et al.   NATURE BIOTECHNOLOGY

Limits to research risks

(2009) F G Miller et al.   JOURNAL OF MEDICAL ETHICS